Home - Products - Autophagy - CXCR - Delmetacin

Delmetacin

CAS No. 16401-80-2

Delmetacin( —— )

Catalog No. M36154 CAS No. 16401-80-2

Delmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	114	Get Quote
5MG	170	Get Quote
10MG	257	Get Quote
25MG	466	Get Quote
50MG	626	Get Quote
100MG	891	Get Quote
500MG	1782	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Delmetacin
Note

Research use only, not for human use.
Brief Description

Delmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.
Description

Delmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Autophagy
Target

CXCR
Recptor

CXCR
Research Area

——
Indication

——

Chemical Information

CAS Number

16401-80-2
Formula Weight

293.32
Molecular Formula

C18H15NO3
Purity

>98% (HPLC)
Solubility

——
SMILES

C(=O)(N1C=2C(C(CC(O)=O)=C1C)=CC=CC2)C3=CC=CC=C3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Delmetacin

Delmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.
AZD8797

AZD8797 (KAND567) is an orally available, selective and potent human CX3CR1-converting antagonist with inhibitory effects on CX3CR1 and CXCR2.
CXCL-CXCR1/2-IN-1

CXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer.

Sign In Join Free